Methodological considerations in using patient reported measures in dialysis clinics
- PMID: 29757314
- PMCID: PMC5934925
- DOI: 10.1186/s41687-017-0010-9
Methodological considerations in using patient reported measures in dialysis clinics
Abstract
Patient reported measures (PRMs), including patient-reported outcomes, play a critical role in dialysis care. The usage of PRMs is extensive in dialysis clinics. While there are excellent PRMs to choose from, and their implementation as part of quality improvement and performance monitoring is extensive, there are still methodological challenges to be addressed. In this paper, we identify key methodological concerns around use of PRMs in dialysis centers in the United States and make recommendations for improving the use of PRMs in dialysis related to Selection of PRMs, Mode of Administration, and Support for PRM Use. These recommendations include: (1) Continue the use of Kidney Disease Quality of Life 36-item survey (KDQOL™-36) for dialysis centers' internal quality improvement activities and the In-Center Hemodialysis Consumer Assessment of Health Care Providers and Systems (ICH-CAHPS survey®) for public dialysis center performance monitoring, but promote efforts to modify these instruments by incorporating PROMIS general health items (KDQOL-36) and reducing the length of the ICH-CAHPS. (2) Adopt a PRM of whether dialysis patients have been informed about all dialysis and transplant options. (3) Evaluate equivalence between electronic and paper versions of PRMs prior to widespread use of electronic administration. (4) Explore reimbursement of costs of PRM administration by the Centers for Medicare and Medicaid Services and kidney organizations. (5) Continue development of provider trainings in PRM administration and interpretation. These recommendations will help dialysis care decision-makers, clinicians, and applied researchers take the next steps toward enhancing PRM use in dialysis.
Keywords: Dialysis; Outcomes; Patient reported measures.
Conflict of interest statement
The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis survey.Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1099-108. doi: 10.2215/CJN.10121013. Epub 2014 May 15. Clin J Am Soc Nephrol. 2014. PMID: 24832092 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Online Reviews of Hemodialysis Centers Correlate With Medicare and Medicaid Survey Measures of Patient Experience.Qual Manag Health Care. 2021 Oct-Dec 01;30(4):213-218. doi: 10.1097/QMH.0000000000000314. Qual Manag Health Care. 2021. PMID: 34326289
-
Using Patient Experience Survey Data to Improve In-Center Hemodialysis Care: A Practical Review.Am J Kidney Dis. 2020 Sep;76(3):407-416. doi: 10.1053/j.ajkd.2019.12.013. Epub 2020 Mar 19. Am J Kidney Dis. 2020. PMID: 32199710 Review.
-
Quality Measures for Dialysis: Time for a Balanced Scorecard.Clin J Am Soc Nephrol. 2016 Feb 5;11(2):363-8. doi: 10.2215/CJN.06010615. Epub 2015 Aug 27. Clin J Am Soc Nephrol. 2016. PMID: 26316622 Free PMC article. Review.
Cited by
-
Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.Toxins (Basel). 2023 Aug 29;15(9):531. doi: 10.3390/toxins15090531. Toxins (Basel). 2023. PMID: 37755957 Free PMC article. Review.
-
A perspective on the use of patient-reported experience and patient-reported outcome measures in ambulatory healthcare.Expert Rev Pharmacoecon Outcomes Res. 2025 Apr;25(4):441-449. doi: 10.1080/14737167.2025.2451749. Epub 2025 Jan 17. Expert Rev Pharmacoecon Outcomes Res. 2025. PMID: 39819211 Review.
-
Problems with analyses and interpretation of data in "use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States".BMC Nephrol. 2019 Dec 3;20(1):447. doi: 10.1186/s12882-019-1609-2. BMC Nephrol. 2019. PMID: 31795976 Free PMC article.
-
The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: a systematic review of reviews.J Patient Rep Outcomes. 2018 Oct 3;2:46. doi: 10.1186/s41687-018-0072-3. eCollection 2018 Dec. J Patient Rep Outcomes. 2018. PMID: 30363333 Free PMC article. Review.
-
Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol.BMJ Open. 2018 Oct 28;8(10):e021532. doi: 10.1136/bmjopen-2018-021532. BMJ Open. 2018. PMID: 30373779 Free PMC article.
References
-
- United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases;2016.
-
- Food and Drug Administration. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Rockville, MD: U.S. Department of Health and Human Services,;2009. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources